Dr Furness completed her medical training at Cambridge and Oxford University and her PhD at the Institute of Cancer Research. She trained in clinical haematology at the Royal Marsden Hospital and ...

Dr Caroline Furness is a Group Leader at the Institute of Cancer Research and a Consultant Paediatric/TYA Haematologist at the Royal Marsden Hospital. She specialises in the care of paediatric ...

Our group's aim is to improve the treatment and survival of children with neuroblastoma, medulloblastoma and rhabdomyosarcoma. The goal of our laboratory is to improve the treatment and survival of ...

A ‘TripAdvisor-style’ website that helps scientists choose the best small-molecule tools for their experiments has been greatly expanded to include expert reviews of hundreds of chemical probes that ...

We identified many of the cancer-causing chemicals in cigarette smoke and coal tar – including the first pure carcinogen ever to be isolated We now know that exposure to certain chemicals, such as ...

More than 110,000 women were recruited from across the UK from 2004 to 2011. The study collects extensive, high-quality data through participant recruitment and follow up questionnaires; blood samples ...

Sonia Bhandal was just 14 when she lost her mum to secondary breast cancer. Then at the age of 28, she found a malignant lump in her own breast. Shortly afterwards she discovered that she carries the ...

The goal of our laboratory is to improve the treatment and survival of children with neuroblastoma, medulloblastoma and rhabdomyosarcoma, three paediatric solid tumours in which high-risk patient ...

Sentinal4D, a spinout company from The Institute of Cancer Research, London, has been announced to the public – having closed its first round of funding and appointed its foundational leadership team.

It’s been a busy year here in the ICR’s Business and Innovation Office (BIO)! Here are just some of the things we’ve been excited about. The year started with news that Socius and Aviva have joined ...